Small Molecule Therapeutics Center

The PACCM Center for Small Molecule Therapeutics was established in 2015 to increase the scientific understanding and collaborative efforts on developing small molecules that target various pulmonary diseases including ARDS, Asthma, IPF, COPD, Transplant rejection, etc. The mission of the SMTC is to provide our expertise in protein modeling, target validation, small molecule screening, “hits” identification and optimization, in vitro ADME and referrals for additional medicinal or synthetic chemists to the appropriate facilities within PACCM and the Department of Medicine. The center provides an excellent platform for faculty collaboration which hopefully can lead to novel treatments for patients with pulmonary diseases.

CONTACT:   Bill Chen, PhD  |  chenb@upmc.edu  |  412-383-4416